“Pharmaceuticals is the second industry to come under the microscope in this series. Broadly part of the health-care industry and the subject of intense public and private debate, drug manufacturers may undergo massive changes in the near future.
In terms of raising capital—our focus in this series of articles—a few basics need reiteration. The population of the highly industrialized nations is aging. Baby boomers in the United States fret about retirement but know the power of pharmaceutical breakthroughs. Drug manufacturers continue to rack up massive profits. Take Johnson & Johnson (NYSE: JNJ), for example. From 2006 to 2008, revenue rose $10 billion. Profits are also way up…”
To read Michael McTague’s full article, click here. To access future issues of the magazine and stay up-to-date with the latest financial happenings, sign up for a free one-year subscription to EQUITIES Magazine.
About EQUITIES:
Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.
